# Ethical Dilemma Analysis — MediAssist at Riverside Community Hospital

## Stakeholders (who is affected and how)

1) **Current ER Patients**: A *current patient* / *ER patient* faces immediate effects on **triage** and **treatment**: MediAssist could change **care quality**, **diagnosis** accuracy for **life-threatening** cases, and **speed** / **wait** times during the initial assessment.

2) **Future Patients**: A *future patient* population may experience **long-term** changes **over time** if the system can **learn** from **data** and **continuous** improvement, potentially **improve** outcomes later, but also potentially entrench errors if the data feedback loop is biased.

3) **ER Nursing Staff**: *Nurs*es and other ER *staff* are directly affected in **job security** terms because 4 *position*s are slated to be **cut** through **attrition**, and their day-to-day **work** **conditions** may shift (more supervision of a tool, less bedside interaction, and accountability for AI-influenced triage decisions).

4) **Hospital Administration**: The *hospital board* / *admin* team must make a **decision** balancing **budget** and **cost** (including $2.3M/5 years and an extra $400K pilot), plus **liability**, **regulatory** **compliance**, and **reputation** concerns if outcomes worsen for any subgroup.

5) **TechHealth Corp**: *TechHealth* is the system’s commercial provider; its **commercial** **profit** incentives and the **contract** requirement to send interaction **data** to its servers create strong **business** interests in deployment and in the **value** of patient data for product improvement and revenue.

6) **Rural Community Members**: *Rural* residents (about **35%** of the service area) may face **access** and **representation** problems because the **training data** reportedly includes only **3%** rural patients, raising **disparity** and **bias** / **underrepresent**ation concerns and the possibility of **worse** performance for this group.

## The four value conflicts (ethical tensions)

1) **Patient Safety vs. Resource Efficiency**: There is a **tradeoff** between improving average **safety** (more **accurate** detection of **life-threatening** conditions) and pursuing **efficient** use of resources (**speed**, **cost**, and **budget** constraints). The dilemma is whether gains for many justify added **risk** of harm to specific populations (e.g., older adults and rural patients).

2) **Individual Privacy vs. Collective Benefit**: A clear **tension** exists between individual **privacy** / confidentiality of **patient data** (and **data sharing** to outside servers) and the **collective** goal to **improve** care for everyone by letting the model **learn** continuously from aggregate data for broader benefit.

3) **Current Workers vs. Future Patients**: There is a **conflict** between protecting **job**s and livelihoods of nurses and other **worker**s now versus investing in tools that might fund **better care** for the *future patient* population (future outcomes, future quality) by reallocating money away from staffing.

4) **Innovation Adoption vs. Precautionary Principle**: The hospital can **adopt** an **innovation** early and capture benefits quickly, **but** the **precaution**ary approach emphasizes being **careful** about **unknown** and **uncertain** risks (including subgroup performance and usability barriers) before scaling.

## Action analysis (Options 1–4)

### Option 1: Deploy fully (full deploy / deploy full) in the ER next month
- **Pro**: Potentially **faster** triage and **more accurate** identification of life-threatening conditions; may **improve** throughput and be more **efficient**.
- **Pro**: Creates more real-world data that can **enhance** learning and support future quality improvements.
- **Con**: Higher **risk** of **harm** to patients over 75 if performance is **worse** for that group; also a **disadvantage** for elderly/disabled users facing touchscreen barriers.
- **Con**: Privacy and governance **issue**: sending interaction data to external servers is a major **concern** and may increase legal/compliance exposure.

### Option 2: Reject MediAssist and continue current human-only triage
- **Pro**: Avoids immediate privacy and subgroup-bias concerns; preserves existing workflows and reduces unknown adoption risk.
- **Pro**: Avoids the near-term **cost** and prevents “automation bias” from affecting triage.
- **Con**: Misses the potential benefit of higher overall accuracy and faster assessments; could be a negative opportunity cost for safety.
- **Con**: Does not generate new data for improvement; may fail to address current ER crowding and wait-time problems.

### Option 3: Pilot MediAssist for 6 month trial in parallel with human triage
- **Pro**: A pilot in **parallel** can improve safety by keeping human oversight while collecting evidence; it supports careful evaluation before scale.
- **Pro**: Enables targeted measurement of bias (age 75+ and rural) and usability problems and allows iterative fixes.
- **Con**: Extra **cost** (+$400K) is a real drawback for a public hospital and may divert resources from care.
- **Con**: Operational complexity is a problem: parallel workflows can slow staff, create confusion, and complicate accountability.

### Option 4: Negotiate modified terms with TechHealth (renegotiate / change contract)
- **Pro**: Negotiation could reduce privacy risk (limit data sharing, on-prem processing, stricter de-identification) and improve governance.
- **Pro**: Could require performance guarantees, auditing, or accessibility accommodations, improving fairness and safety.
- **Con**: Uncertain timeline and the company may refuse; delays could keep current inefficiencies in place.
- **Con**: Even with new terms, technical limitations and residual bias may persist; contract changes may not fully solve the underlying issues.

## Recommendation

**My recommendation** is **Option 3 (pilot)**: run a 6 month pilot in parallel with human triage, with predefined safety thresholds and subgroup audits, and use that evidence to decide whether to scale.

**First** reason: the pilot balances the safety-vs-efficiency tradeoff by capturing potential benefits (faster, more accurate triage) while limiting risk through human oversight **because** the hospital can detect and correct harms before full deployment.

**Second** reason: it directly addresses equity and privacy tensions by generating local evidence on rural representation and age performance, and it creates leverage to negotiate safeguards; **therefore** it supports a more responsible go/no-go decision than immediate full deployment.

## Limitations / uncertainties

A key **limitation** is that a pilot still costs money and may not reflect full-scale behavior; results depend on implementation quality and the hospital’s monitoring capacity. Another uncertainty is that this approach **depends on** how data handling is configured and **if TechHealth** will allow meaningful auditing and privacy-preserving changes; outcomes are **uncertain** and the plan is imperfect, **however** it reduces irreversible downside relative to immediate full deployment.
